List of Tables
Table 1. Non Small Cell Lung Cancer Treatment Market Trends
Table 2. Non Small Cell Lung Cancer Treatment Market Drivers & Opportunity
Table 3. Non Small Cell Lung Cancer Treatment Market Challenges
Table 4. Non Small Cell Lung Cancer Treatment Market Restraints
Table 5. Global Non Small Cell Lung Cancer Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Non Small Cell Lung Cancer Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Non Small Cell Lung Cancer Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Non Small Cell Lung Cancer Treatment
Table 10. Global Non Small Cell Lung Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Non Small Cell Lung Cancer Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Non Small Cell Lung Cancer Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Non Small Cell Lung Cancer Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Non Small Cell Lung Cancer Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Non Small Cell Lung Cancer Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Non Small Cell Lung Cancer Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Non Small Cell Lung Cancer Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Non Small Cell Lung Cancer Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Non Small Cell Lung Cancer Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Non Small Cell Lung Cancer Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Non Small Cell Lung Cancer Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Non Small Cell Lung Cancer Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Non Small Cell Lung Cancer Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Non Small Cell Lung Cancer Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Non Small Cell Lung Cancer Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Non Small Cell Lung Cancer Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Non Small Cell Lung Cancer Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Non Small Cell Lung Cancer Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Novartis AG Basic Information List
Table 32. Novartis AG Description and Business Overview
Table 33. Novartis AG Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Novartis AG (2019-2024)
Table 35. Novartis AG Recent Developments
Table 36. Pfizer Inc Basic Information List
Table 37. Pfizer Inc Description and Business Overview
Table 38. Pfizer Inc Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Pfizer Inc (2019-2024)
Table 40. Pfizer Inc Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. F. Hoffmann-La Roche Ltd Basic Information List
Table 47. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 48. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of F. Hoffmann-La Roche Ltd (2019-2024)
Table 50. F. Hoffmann-La Roche Ltd Recent Developments
Table 51. Astrazeneca Basic Information List
Table 52. Astrazeneca Description and Business Overview
Table 53. Astrazeneca Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Astrazeneca (2019-2024)
Table 55. Astrazeneca Recent Developments
Table 56. Eli Lilly and Company Basic Information List
Table 57. Eli Lilly and Company Description and Business Overview
Table 58. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Eli Lilly and Company (2019-2024)
Table 60. Eli Lilly and Company Recent Developments
Table 61. Merck & Co Inc Basic Information List
Table 62. Merck & Co Inc Description and Business Overview
Table 63. Merck & Co Inc Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Merck & Co Inc (2019-2024)
Table 65. Merck & Co Inc Recent Developments
Table 66. Bristol-Myers Squibb Company Basic Information List
Table 67. Bristol-Myers Squibb Company Description and Business Overview
Table 68. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Bristol-Myers Squibb Company (2019-2024)
Table 70. Bristol-Myers Squibb Company Recent Developments
Table 71. Celgene Corporation Basic Information List
Table 72. Celgene Corporation Description and Business Overview
Table 73. Celgene Corporation Non Small Cell Lung Cancer Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Non Small Cell Lung Cancer Treatment Business of Celgene Corporation (2019-2024)
Table 75. Celgene Corporation Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Non Small Cell Lung Cancer Treatment Downstream Customers
Table 79. Non Small Cell Lung Cancer Treatment Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Non Small Cell Lung Cancer Treatment Product Picture
Figure 2. Global Non Small Cell Lung Cancer Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non Small Cell Lung Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Non Small Cell Lung Cancer Treatment Report Years Considered
Figure 5. Global Non Small Cell Lung Cancer Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Non Small Cell Lung Cancer Treatment Revenue in 2023
Figure 7. Non Small Cell Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Chemotherapy Picture
Figure 9. Targeted Therapy Picture
Figure 10. Immunotherapy Picture
Figure 11. Global Non Small Cell Lung Cancer Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Non Small Cell Lung Cancer Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Clinic
Figure 15. Product Picture of Others
Figure 16. Global Non Small Cell Lung Cancer Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Non Small Cell Lung Cancer Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Non Small Cell Lung Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Non Small Cell Lung Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Non Small Cell Lung Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Non Small Cell Lung Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Non Small Cell Lung Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Non Small Cell Lung Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Non Small Cell Lung Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Non Small Cell Lung Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Non Small Cell Lung Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Non Small Cell Lung Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Non Small Cell Lung Cancer Treatment Sales Value (%), (2019-2030)
Figure 29. United States Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. China Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. China Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. India Non Small Cell Lung Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Non Small Cell Lung Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. India Non Small Cell Lung Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. Non Small Cell Lung Cancer Treatment Industrial Chain
Figure 51. Non Small Cell Lung Cancer Treatment Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
